Elliss Harry, Proctor Kit, Robertson Megan, Bagnall John, Kasprzyk-Hordern Barbara
Department of Chemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK.
Centre of Excellence in Water-Based Early-Warning Systems for Health Protection, University of Bath, Claverton Down, Bath, BA2 7AY, UK.
Anal Bioanal Chem. 2025 Sep 13. doi: 10.1007/s00216-025-06097-3.
This manuscript establishes a new, comprehensive biomarker list and a multiresidue trace quantification method for community-wide health and well-being assessment at a metropolitan scale using wastewater-based epidemiology (WBE) and mass spectrometry pipelines. This method enables the quantification of 204 biochemical indicators (BCIs) across a range of biomarker classes within influent wastewater and includes illicit drug BCIs, pharmaceuticals as proxies for disease, health markers (hormones, oxidative stress, lipid peroxidation, etc.), Lifestyle chemicals, food BCIs, and hazardous chemicals in personal care products. This method facilitates the combined assessment of community exposure to chemicals and the effects of this exposure in the same framework. The method enables full quantification of 141 BCIs with method detection Limits varying from 0.01 ng/L for amlodipine to 23.8 ng/L for stachydrine. Total average method accuracies were 102.7% whereas precision was 10.4%. During an initial assessment of this method to test its suitability, 62% of all targets were detected and quantified during a week-long feasibility study of a large city with weekly average Daily BCI loads ranging from 40.0 ± 20.0 mg/day for salbutamol to 5836.5 ± 1697.1 g/day for creatinine. The inclusion of new endogenous markers such as advanced glycation end products, detected in wastewater for the first time, enables more accurate determination of community-level health and lifestyle habits. Alongside an unbiased and comprehensive health assessment through endogenous markers, health is further assessed via the use of pharmaceuticals, acting as a proxy for health and disease status whilst additionally providing insights into community lifestyle habits through the monitoring of licit/illicit drug use and food consumption. The analysis of all biomarker classes combined aims to provide insights to exposure and health effect outcomes at the community level.
本手稿建立了一个全新的、全面的生物标志物清单以及一种多残留痕量定量方法,用于在大都市尺度上利用基于污水的流行病学(WBE)和质谱分析流程进行社区范围的健康与福祉评估。该方法能够对进水污水中一系列生物标志物类别的204种生化指标(BCIs)进行定量,包括非法药物BCIs、作为疾病替代指标的药物、健康标志物(激素、氧化应激、脂质过氧化等)、生活方式化学品、食品BCIs以及个人护理产品中的有害化学品。此方法有助于在同一框架内对社区化学品暴露及其影响进行综合评估。该方法能够对141种BCIs进行完全定量,方法检测限从氨氯地平的0.01 ng/L到水苏碱的23.8 ng/L不等。总平均方法准确度为102.7%,而精密度为10.4%。在对该方法进行初步评估以测试其适用性时,在一个大城市为期一周的可行性研究中,62%的所有目标被检测和定量,该城市每周平均每日BCI负荷范围从沙丁胺醇的40.0±20.0 mg/天到肌酐的5836.5±1697.1 g/天。首次在污水中检测到的新内源性标志物(如晚期糖基化终产物)的纳入,能够更准确地确定社区层面的健康状况和生活方式习惯。除了通过内源性标志物进行无偏且全面的健康评估外,还通过使用药物进一步评估健康状况,药物作为健康和疾病状态的替代指标,同时通过监测合法/非法药物使用和食品消费,还能深入了解社区生活方式习惯。对所有生物标志物类别进行综合分析的目的是为社区层面的暴露和健康影响结果提供见解。